CEO confirms Q2 2026 procedure growth of 16% as Ion procedures surge 36%, aligning with long-term targets.
Intuitive Surgical maintained its 2026 da Vinci procedure growth outlook of 13.5%-15.5% after reporting a 16% increase in total procedures for Q2 2026. The company cited 15% growth in da Vinci procedures and a 36% jump in Ion procedures as key drivers.
The non-GAAP gross margin range was set at 68%-69%, consistent with prior guidance. Q2 performance exceeded some analyst expectations, though the company reiterated its full-year targets without adjustment.
Shares showed muted reaction in after-hours trading as investors digested the steady outlook alongside strong quarterly execution.